Service Updates

Legislated changes to patient access to pathology results in My Health Record 1 July 2026 15 June 2026 Legislated changes to patient access to pathology results in My Health Record 1 July 2026 From 1 July 2026, new national"Share by Default"legislation will require most pathology results to be uploaded to My Health Record shortly after they are released, unless a defined exception applies. This means patients may be able to see their results before speaking with their doctor or healthcare provider. What is changing? PathWest is implementing this legislated changeandraising awarenesswith hospital and community clinicians and patients ahead of commencement. Patients mayview results before clinical follow‑up A5‑day legislated delay applies only to: Anatomical pathology Cytopathology Genetic testing Patient choice Patients can: Opt-out of My Health Record Restrict or remove specific results Results will be shared unless patients opt-o...

PathWest transitioning from SafetyLok™ butterfly needles to BD UltraTouch™ safety needles 27 March 2026 PathWest has commenced a full product conversion from the current Safety-Lok™ Butterfly Wingset to the new BD UltratouchTM Push Button Wingset. What is changing? From 1 July 2026, PathWest will stock and supply the BD UltraTouchTM Push Button Wingset. If your clinic intends to order this product through PathWest, it is important that clinical staff are fully trained and confident with the device p...

PathWest Electronic Results via Healthlink are now available to health professionals 16 February 2026 Healthcare professionals can now access PathWest results electronically through Healthlink. Thank you for working together with us to ensure timely and secure access to pathology results, supporting the best care for your patients. More information Contact for setup or support PathWest Electronic Results Support E:pathwestelectronicresultssupport@health.wa.gov.au T:(08) 6383 4900 or 13 7284 ...

PathWest transitions to updated AS/NZS 4308:2023 standard 10 November 2025 PathWest transitions to updated AS/NZS 4308:2023 standard PathWest has now fully transitioned to the updated Australian Standard AS/NZS 4308:2023 – Procedures for specimen collection, testing and the quantification of drugs in urine. The new standard introduces revised cut-off thresholds for several drug classes and updated reporting formats for amphetamine-type substances and benzodiazepines to e...

Hereditary Alpha-Tryptasaemia (HaT) Testing 22 September 2025 Hereditary Alpha-Tryptasaemia (HaT) Testing PathWest Laboratory Medicine WA is pleased to offer Australia’s first NATA-accredited test for Hereditary Alpha-Tryptasaemia (HαT). Benefits of HαT testing HaT is an important differential to Mastocytosis where there is elevated mast cell tryptase. In this setting early identification can: Avoid invasive bone marrow biopsies ...